CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Marcel Bonn-Miller

OPENALEX: A5012132569↗ORCID: 0000-0001-5088-5386↗

Affiliations

Organizations

Center for Excellence in Educationauthorship · US Center for Innovationauthorship · US May Instituteauthorship · US National Center for Post Traumatic Stress Disorderauthorship · US National Center for PTSDauthorship · US Office of the Directorauthorship · US Philadelphia VA Medical Centerauthorship · US The University of Texas MD Anderson Cancer Centerauthorship · US TWT GmbH Science & Innovation (Germany)authorship · DE University of Houstonauthorship · US University of Michiganauthorship · US University of Pennsylvaniaauthorship · US University of Vermontauthorship · US U.S. National Science Foundationauthorship · US VA Center for Clinical Management Researchauthorship · US VA Palo Alto Health Care Systemauthorship · US Zynerba Pharmaceuticals (United States)authorship · US

Public evidence

16 connected articles

An Unexpected Activity of a Minor Cannabinoid: Cannabicyclol (CBL) Is a Potent Positive Allosteric Modulator of Serotonin 5-HT<sub>1A</sub> Receptor.2025 · Europe PMC Serum Markers of Bone Turnover Following Controlled Administration of Two Medical Cannabis Products in Healthy Adults.2024 · Europe PMC Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants.2024 · Europe PMC Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.2022 · Europe PMC Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol: a pilot study.2022 · Europe PMC Online survey of medicinal cannabis users: Qualitative analysis of patient-level data.2022 · Europe PMC Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.2022 · Europe PMC Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial.2021 · Europe PMC A Cross-Sectional and Prospective Comparison of Medicinal Cannabis Users and Controls on Self-Reported Health.2021 · PubMed Central Open Access Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model <i>Caenorhabditis elegans</i>.2021 · Europe PMC

Registered research

Connected studies

An Exploratory Study to Evaluate the Safety and Efficacy of Microneedling With Cannabidiol (CBD) and Hempseed Oil for Treating Acne Vulgarisnct06362889

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature.

2019 · Europe PMC

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.2019 · Europe PMC

Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.2017 · Europe PMC

Preliminary Development of a Brief Cannabis Use Disorder Screening Tool: The Cannabis Use Disorder Identification Test Short-Form.2016 · PubMed Central Open Access

Training and Practices of Cannabis Dispensary Staff.2016 · Europe PMC

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders2015 · PubMed Central Open Access

Marcel Bonn-Miller - Medical Cannabis Research Engine